Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses.

about

Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort.Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract.

P2860

Q38401295-F5AF373B-BD45-4499-99F3-CE7010A93640 Q47304240-D11CD816-7002-4503-B335-4E9D6C4D8925

P2860

Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses.

Item

http://www.wikidata.org/entity/Q35842876

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Malignancy risk of anti-tumor ...... tic reviews and meta-analyses.

@ast

Malignancy risk of anti-tumor ...... tic reviews and meta-analyses.

@en

type

Item

label

Malignancy risk of anti-tumor ...... tic reviews and meta-analyses.

@ast

Malignancy risk of anti-tumor ...... tic reviews and meta-analyses.

@en

prefLabel

Malignancy risk of anti-tumor ...... tic reviews and meta-analyses.

@ast

Malignancy risk of anti-tumor ...... tic reviews and meta-analyses.

@en

P1476

Malignancy risk of anti-tumor ...... tic reviews and meta-analyses.

@en

P2093

Gang Liu

http://www.w3.org/2001/XMLSchema#string

Jianhong Sun

http://www.w3.org/2001/XMLSchema#string

Yuan Yang

http://www.w3.org/2001/XMLSchema#string

Yuehong Chen

http://www.w3.org/2001/XMLSchema#string

Yupeng Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Biologics, cardiovascular effects and cancer

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

The role of biological agents in the management of large vessel vasculitis (LVV): a systematic review and meta-analysis

Cancer risk of anti-TNF-α at recommended doses in adult rheumatoid arthritis: a meta-analysis with intention to treat and per protocol analyses

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.

Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials.

Meta-analysis: the efficacy and safety of certolizumab pegol in Crohn's disease.

Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic review.

Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.

P304

1-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1007/S10067-015-3115-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26573205

http://www.w3.org/2001/XMLSchema#string

P921

meta-analysis

Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses.

about

P2860

P2860

Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921